Tower Research Capital »

Atea Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $31k 9.5k 3.31
2024-03-31 $5.9k 1.5k 4.04
2023-09-30 $40k 13k 3.00
2023-06-30 $22k 5.7k 3.74
2023-03-31 $11k 3.2k 3.49
2022-12-31 $102k 21k 4.83
2022-09-30 $102k 18k 5.73
2022-06-30 $167k 24k 7.12
2022-03-31 $9.3k 1.3k 7.16
2021-12-31 $0 1.3k 0.00
2021-09-30 $231k 6.6k 35.04
2021-06-30 $36k 1.7k 21.42
2021-03-31 $45k 729 61.73
2020-12-31 $14k 332 42.17